Sara Brin Rosenthal
Overview
Explore the profile of Sara Brin Rosenthal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi V, Carter D, Chen A, Murphy K, Higgins J, Gurel M, et al.
PLoS One
. 2025 Jan;
19(12):e0312615.
PMID: 39775546
Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (MASH), is a major risk factor for cirrhosis and hepatocellular carcinoma (HCC) and a leading cause of liver transplantation. MASH is...
2.
Linner R, Mallard T, Barr P, Sanchez-Roige S, Madole J, Driver M, et al.
Nat Neurosci
. 2024 Dec;
28(1):213.
PMID: 39643700
No abstract available.
3.
Kim H, Rosenthal S, Liu X, Miciano C, Hou X, Miller M, et al.
J Hepatol
. 2024 Nov;
PMID: 39522884
Background & Aims: Metabolic dysfunction-associated steatotic liver disease ranges from metabolic dysfunction-associated steatotic liver (MASL) to metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis. Transdifferentiation of hepatic stellate cells (HSCs) into fibrogenic...
4.
Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
Ganguly S, Rosenthal S, Ishizuka K, Troutman T, Rohm T, Khader N, et al.
Proc Natl Acad Sci U S A
. 2024 Aug;
121(35):e2405746121.
PMID: 39172787
While macrophage heterogeneity during metabolic dysfunction-associated steatohepatitis (MASH) has been described, the fate of these macrophages during MASH regression is poorly understood. Comparing macrophage heterogeneity during MASH progression vs regression,...
5.
Fisch K, Rosenthal S, Mark A, Sasik R, Nasamran C, Clifford R, et al.
BMC Genomics
. 2024 Jun;
25(1):646.
PMID: 38943082
Background: Ménière's disease (MD) is a disorder of the inner ear that causes episodic bouts of severe dizziness, roaring tinnitus, and fluctuating hearing loss. To date, no targeted therapy exists....
6.
Martellucci S, Flutsch A, Carter M, Norimoto M, Pizzo D, Mantuano E, et al.
Glia
. 2024 Feb;
72(5):916-937.
PMID: 38372375
Schwann cells (SCs) undergo phenotypic transformation and then orchestrate nerve repair following PNS injury. The ligands and receptors that activate and sustain SC transformation remain incompletely understood. Proteins released by...
7.
Kim H, Sakane S, Eguileor A, Carvalho Gontijo Weber R, Lee W, Liu X, et al.
Cell Mol Gastroenterol Hepatol
. 2023 Sep;
17(1):93-106.
PMID: 37743012
Liver fibrosis of different etiologies is a serious health problem worldwide. There is no effective therapy available for liver fibrosis except the removal of the underlying cause of injury or...
8.
Qualliotine J, Nakagawa T, Rosenthal S, Sadat S, Ballesteros-Merino C, Xu G, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686653
HPV-associated oropharynx carcinoma (HPVOPC) tumors have a relatively low mutational burden. Elucidating the relative contributions of other tumor alterations, such as DNA methylation alterations, alternative splicing events (ASE), and copy...
9.
Wright S, Leger B, Rosenthal S, Liu S, Jia T, Chitre A, et al.
Cell Rep
. 2023 Aug;
42(8):112873.
PMID: 37527041
A vexing observation in genome-wide association studies (GWASs) is that parallel analyses in different species may not identify orthologous genes. Here, we demonstrate that cross-species translation of GWASs can be...
10.
Niemsiri V, Rosenthal S, Nievergelt C, Maihofer A, Marchetto M, Santos R, et al.
Mol Psychiatry
. 2023 Mar;
29(1):6-19.
PMID: 36991131
Lithium (Li) is one of the most effective drugs for treating bipolar disorder (BD), however, there is presently no way to predict response to guide treatment. The aim of this...